دورية أكاديمية

Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.

التفاصيل البيبلوغرافية
العنوان: Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.
المؤلفون: Brass, Lawrence M., Lichtman, Judith H., Wang, Yun, Gurwitz, Jerry H., Radford, Martha J., Krumholz, Harlan M.
المساهمون: Department of Medicine, Division of Geriatric Medicine, Meyers Primary Care Institute
المصدر: Stroke; a journal of cerebral circulation ; 31 ; 8
بيانات النشر: Lippincott Williams & Wilkins
سنة النشر: 2022
المجموعة: University of Massachusetts, Medical School: eScholarship@UMMS
مصطلحات موضوعية: Age Factors, Aged, Cohort Studies, Female, Fibrinolytic Agents, Humans, Incidence, Intracranial Hemorrhages, Male, Myocardial Infarction, Retrospective Studies, Risk Factors, Survival Rate, Thrombolytic Therapy, Health Services Research, Medicine and Health Sciences
الوصف: BACKGROUND AND PURPOSE: Intracranial hemorrhage is a serious complication of thrombolytic therapy for acute myocardial infarction, especially among the elderly, but little information exists on estimating risk. Better estimation of risk in individual patients may allow for withholding or using alternate therapies among those at highest risk. METHODS: To quantify the risk and identify predictors of intracranial hemorrhage associated with thrombolytic therapy, we performed a retrospective cohort study using data from medical charts. The study involved nearly all acute-care hospitals in the United States. All Medicare patients discharged with a principal diagnosis of acute myocardial infarction during a 9-month period in 1994 to 1995 were included. The main outcome measure was intracranial hemorrhage among those treated with thrombolytic therapy. RESULTS: The rate of intracranial hemorrhage was 1.43% (455 of 31 732). In a logistic model, age > or =75 years, female, black race, prior stroke, blood pressure > or =160 mm Hg, tissue plasminogen activator (versus other thrombolytic agent), excessive anticoagulation (international normalized ratio > or =4 or prothrombin time > or =24), and below median weight (< or =65 kg for women; < or =80 kg for men) were independent predictors. A risk stratification scale was developed on the basis of these factors: with none or 1 of the factors (n=6651), the rate of intracranial hemorrhage was 0.69%; with 2 factors (n=10 509), 1.02%; with 3 factors (n=9074), 1.63%; with 4 factors (n=4298), 2.49%; and with > or =5 factors (n=1071), 4. 11% (Mantel-Haenszel; P<0.001). CONCLUSIONS: The rate of intracranial hemorrhage in older patients after treatment with thrombolytic therapy exceeds 1%. Readily available factors can identify elderly patients with acute myocardial infarction at high and low risk for intracranial hemorrhage associated with thrombolytic therapy.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0039-2499
العلاقة: Link to article in PubMed; http://stroke.ahajournals.org/cgi/content/full/31/8/1802Test; Stroke. 2000;31:1802.; http://hdl.handle.net/20.500.14038/37337Test; https://escholarship.umassmed.edu/meyers_pp/92Test; 1019443; meyers_pp/92
الإتاحة: https://doi.org/20.500.14038/37337Test
https://hdl.handle.net/20.500.14038/37337Test
https://escholarship.umassmed.edu/meyers_pp/92Test
رقم الانضمام: edsbas.FBBDFC2F
قاعدة البيانات: BASE